Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-13-005428
Filing Date
2013-09-27
Accepted
2013-09-27 17:02:26
Documents
1
Period of Report
2013-09-25

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4092513warusz_soligenix.html 4  
1 OWNERSHIP DOCUMENT f4092513warusz_soligenix.xml 4 4359
  Complete submission text file 0001213900-13-005428.txt   5998
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Issuer) CIK: 0000812796 (see all company filings)

EIN.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12 TEAL DRIVE LANGHORNE PA 19047
Business Address
Warusz Joseph Michael (Reporting) CIK: 0001468000 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-16929 | Film No.: 131120550